Latest Methylnaltrexone Stories
First-in-class treatment approved for adult patients with opioid-induced constipation who have had an inadequate response to laxatives SAN FRANCISCO, Dec.
SAN FRANCISCO, Sept.
Gallus BioPharmaceuticals, LLC, a premier, full service biopharmaceutical contract development and manufacturing organization announced today that it has been selected by Progenics Pharmaceuticals,
SAN FRANCISCO, June 11, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR), a biopharmaceutical company developing novel pain and cancer therapeutics, today announced that NASDAQ has halted
Pain medicines often lead to constipation for patients seeking long-term pain relief, but an investigational once-daily drug may help.
Achieve Clinical Research is conducting a randomized clinical study to evaluate the safety, tolerability, and efficacy of a new drug for the treatment of
- To give a box on the ear to.